Elizabeth (Beth) Halpern
Beth Halpern helps healthcare clients achieve coverage and reimbursement for innovative technologies. She advises pharmaceutical and device manufacturers, healthcare providers, and trade associations about Medicare and other payers' policies and develops strategies to improve access to care. Beth helps clients advocate before administrative agencies and Congress, and she advises about Medicare law for clients involved in litigation.
In more than 10 years of practice, Beth has worked with clients on securing coding, coverage, and reimbursement for many new drugs, devices, and medical services. By analyzing the regulatory landscape, including Medicare's payment systems for drugs and biologicals, physicians, hospitals, dialysis clinics, and durable medical equipment, she has helped clients benefit from health reform and take advantage of incentive payments for new technologies. She advises clients not only about what the law is now, but also about how to change the law, drafting amendments to the Medicare law and successfully advocating for changes to regulations and coverage policies.
Beth frequently speaks at conferences on coverage, coding, and payment and testifies before advisory committees to the Centers for Medicare & Medicaid Services. During secondments to a large biotechnology company, Beth also served as in-house counsel, advising on government affairs and promotional compliance matters.
The American Health Lawyers Association recognized Beth as a member of the Hogan Lovells team of Pro Bono Champions for their work with the D.C. Appleseed Center on HIV/AIDS in the District of Columbia. Beth is a member of the Tahirih Justice Center's D.C. Advisory Council, and her work contributed to Hogan Lovells being recognized as Firm of the Year by Tahirih in 2015.
Helped a client obtain increased Medicare reimbursement for an innovative health screening service.
Advises clients about applications for pass-through status for new drugs and devices.
Helped a client obtain changes in Medicare policy to reflect new preventive care guidelines.